NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
55,539,879
Share change
-111,764
Total reported value
$73,445,673
Put/Call ratio
27600%
Price per share
$1.32
Number of holders
80
Value change
-$354,395
Number of buys
26
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q3 2014

As of 30 Sep 2014, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,539,879 shares. The largest 10 holders included Platinum Management (NY) LLC, Commerzbank Aktiengesellschaft /FI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NOMURA HOLDINGS INC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT CO LLP, State Street Corp, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP. This page lists 80 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.